1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,129 | 0,260 | 09:58 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.09. | Alzai Health Corp: Alzai Health starts trading on FSE | 1 | Stockwatch | ||
| 17.08. | Alzai Health Corp: Alzai Health hires Euro Digital for marketing services | 3 | Stockwatch | ||
| ALZAI HEALTH Aktie jetzt für 0€ handeln | |||||
| 17.08. | Alzai Health Corp. gibt Marketingdienstleistungsvereinbarung bekannt | 422 | IR-WORLD | Toronto, Ontario / 17. August 2026 / IRW-Press / Alzai Health Corp. (TSXV: ALZI) (das "Unternehmen"
oder "ALZAI") gibt bekannt, dass mit der Firma Euro Digital Media Ltd. ("Euro Digital") (Adresse:... ► Artikel lesen | |
| 17.08. | Alzai Health Corp.: Alzai Health Corp. Announces Marketing Services Agreement | 396 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 17, 2026) - Alzai Health Corp. (TSXV: ALZI) (the "Company" or "ALZAI") announces that it has entered into a services agreement dated August 12, 2026 (the... ► Artikel lesen | |
| 11.08. | Alzai Health Corp: Alzai, Linus Health explore Alzheimer's AI partnership | 1 | Stockwatch | ||
| 11.08. | ALZAI und Linus Health sondieren KI-gestützte Kooperationen zur Früherkennung eines Alzheimer-Risikos und kognitiver Beeinträchtigungen | 515 | IR-WORLD | TORONTO, ONTARIO UND BOSTON, MASSACHUSETTS / 11. August 2026 / IRW-Press / ALZAI Health Corp. (TSXV: ALZI) freut sich, die Unterzeichnung einer Absichtserklärung
(Memorandum of Understanding... ► Artikel lesen | |
| 11.08. | Alzai Health Corp.: ALZAI and Linus Health Explore AI-Driven Collaborations Aimed at Early Identification of Alzheimer's Disease Risk and Cognitive Impairment | 324 | Newsfile | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - August 11, 2026) - ALZAI Health Corp. (TSXV: ALZI) is pleased to announce that it has entered into a Memorandum of Understanding (MOU)... ► Artikel lesen | |
| 22.07. | XFRA NEW INSTRUMENTS AVAILABLE ON 22.07.2026 | 442 | Xetra Newsboard | The following instruments on XETRA do have their first trading 22.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.07.2026
Aktien
1 CA02262P1036 Alzai Health Corp.
2... ► Artikel lesen | |
| 20.07. | Alzai Health Corp: Alzai licenses AI liver disease detection technology | 1 | Stockwatch | ||
| 20.07. | ALZAI Health Corp. sichert sich exklusive weltweite Lizenz für KI-gestützte Technologie zur Risikoidentifizierung von Lebererkrankungen | 512 | IR-WORLD | TORONTO, ONTARIO - 20. Juli 2026 / IRW-Press / ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" oder das "Unternehmen") freut sich bekannt zu geben, dass das Unternehmen mit MOR Research Applications Ltd.... ► Artikel lesen | |
| 20.07. | Alzai Health Corp.: ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology | 305 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into an exclusive worldwide license agreement... ► Artikel lesen | |
| 06.07. | Alzai Health Corp: Alzai validates AI Alzheimer's screening in U.S. data | 1 | Stockwatch | ||
| 06.07. | ALZAI Health Corp. und Centauri Health Solutions schließen strategische Vermarktungsvereinbarung zur Ausweitung der KI-gestützten Ermittlung des Alzheimer-Risikos in den Vereinigten Staaten | 399 | IR-WORLD | TORONTO, ONTARIO / 2. Juli 2026 / IRW-Press / ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" oder das "Unternehmen") freut sich bekannt zu geben, dass das Unternehmen
eine strategische Kooperationsvereinbarung... ► Artikel lesen | |
| 06.07. | Alzai Health Corp.: ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data | 370 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 6, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven... ► Artikel lesen | |
| 02.07. | Alzai Health Corp: Alzai Health signs U.S. marketing agreement | 2 | Stockwatch | ||
| 02.07. | Alzai Health Corp.: Alzai Health Corp. Signs Strategic U.S. Commercialization Agreement with Centauri Health Solutions to Advance AI-Driven Alzheimer's Risk Identification | 462 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 2, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into a strategic teaming agreement (the... ► Artikel lesen | |
| 10.06. | Alzai Health Corp: Alzai Health closes $4.05M initial public offering | 1 | Stockwatch | ||
| 09.06. | Alzai Health Corp. Completes Initial Public Offering | 276 | GlobeNewswire (Europe) | Not for distribution to U.S. Newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. VANCOUVER... ► Artikel lesen | |
| 05.06. | Alzai Health Corp. Announces TSX Venture Exchange Listing | 265 | GlobeNewswire (Europe) | Not for distribution to U.S. Newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. VANCOUVER... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | Alignment Healthcare earns 4-Star or higher ratings for six plans | ||
| HEARTFLOW | 47,590 | -0,08 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | -0,04 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | -0,05 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| FRESENIUS | 42,480 | +2,14 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| BETA BIONICS | 17,440 | +0,06 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,620 | +2,45 % | Fresenius Medical Care: Plötzlicher Führungswechsel schürt Zweifel an Zukunft - Kurs bricht weiter ein | Der überraschende Führungswechsel bei Fresenius Medical Care lässt die Aktie abstürzen und schürt Spekulationen über einen radikalen Kurswechsel im angeschlagenen Dialysegeschäft. Anleger und Analysten... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| NEUROPACE | 12,390 | 0,00 % | KeyBanc initiates NeuroPace stock coverage with overweight rating |
Das Unternehmen ALZAI HEALTH CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,144 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALZAI HEALTH CORP finden Sie auf Wallstreet Online.